Deng, J., Hua, L., Han, T., Tian, M., Wang, D., Tang, H., . . . Gong, Y. (2020). The CREB-binding protein inhibitor ICG-001: A promising therapeutic strategy in sporadic meningioma with NF2 mutations. Neurooncol Adv.
Styl ChicagoDeng, Jiaojiao, et al. "The CREB-binding Protein Inhibitor ICG-001: A Promising Therapeutic Strategy in Sporadic Meningioma With NF2 Mutations." Neurooncol Adv 2020.
Citace podle MLADeng, Jiaojiao, et al. "The CREB-binding Protein Inhibitor ICG-001: A Promising Therapeutic Strategy in Sporadic Meningioma With NF2 Mutations." Neurooncol Adv 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..